XML 56 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating Activities      
Net earnings $ 221,177,000 $ 204,923,000 $ 24,382,000
Adjustments to reconcile net earnings to net cash provided by operating activities      
Depreciation, depletion, accretion and amortization 274,823,000 279,497,000 307,108,000
Net gain on sale of property, plant & equipment and businesses (9,927,000) (244,222,000) (50,978,000)
Proceeds from sale of future production, net of transaction costs (Note 19) 0 0 153,095,000
Contributions to pension plans (14,047,000) (5,488,000) (4,855,000)
Share-based compensation 18,248,000 23,884,000 22,093,000
Excess tax benefits from share-based compensation (18,376,000) (3,464,000) (161,000)
Deferred tax provision (benefit) 3,069,000 18,378,000 (35,063,000)
Cost of debt purchase 67,075,000 72,949,000 0
(Increase) decrease in assets before initial effects of business acquisitions and dispositions      
Accounts and notes receivable (42,164,000) (25,118,000) (42,260,000)
Inventories (20,925,000) (5,595,000) (7,700,000)
Prepaid expenses (5,288,000) (6,256,000) (765,000)
Other assets 34,863,000 (13,930,000) 12,374,000
Increase (decrease) in liabilities before initial effects of business acquisitions and dispositions      
Accrued interest and income taxes 26,605,000 (3,840,000) (10,937,000)
Trade payables and other accruals 26,491,000 4,229,000 15,485,000
Other noncurrent liabilities (42,702,000) (42,810,000) (26,602,000)
Other, net (15,544,000) 7,199,000 1,283,000
Net cash provided by operating activities 503,378,000 260,336,000 356,499,000
Investing Activities      
Purchases of property, plant & equipment (289,262,000) (224,852,000) (275,380,000)
Proceeds from sale of property, plant & equipment 8,218,000 26,028,000 17,576,000
Proceeds from sale of businesses, net of transaction costs 0 721,359,000 51,604,000
Payment for businesses acquired, net of acquired cash (27,198,000) (284,237,000) (89,951,000)
Increase in restricted cash (1,150,000) 0 0
Other, net (350,000) 33,000 (39,000)
Net cash provided by (used for) investing activities (309,742,000) 238,331,000 (296,190,000)
Financing Activities      
Proceeds from line of credit 441,000,000 93,000,000 156,000,000
Payments of line of credit (206,000,000) (93,000,000) (156,000,000)
Payments of current maturities and long-term debt (695,060,000) (579,829,000) (150,602,000)
Proceeds from issuance of long-term debt 400,000,000 0 0
Debt and line of credit issuance costs (7,382,000) 0 0
Purchases of common stock (21,475,000) 0 0
Proceeds from issuance of common stock 0 30,620,000 3,821,000
Dividends paid (53,214,000) (28,884,000) (5,191,000)
Proceeds from exercise of stock options 72,971,000 23,502,000 9,762,000
Excess tax benefits from share-based compensation 18,376,000 3,464,000 161,000
Other, net (65,000) (5,000) 0
Net cash used for financing activities (50,849,000) (551,132,000) (142,049,000)
Net increase (decrease) in cash and cash equivalents 142,787,000 (52,465,000) (81,740,000)
Cash and cash equivalents at beginning of year 141,273,000 193,738,000 275,478,000
Cash and cash equivalents at end of year $ 284,060,000 $ 141,273,000 $ 193,738,000